Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 15 studies | 37% ± 19% | |
lung | 13 studies | 26% ± 9% | |
peripheral blood | 8 studies | 22% ± 6% | |
intestine | 8 studies | 21% ± 8% | |
eye | 7 studies | 31% ± 14% | |
kidney | 5 studies | 24% ± 4% | |
heart | 5 studies | 25% ± 5% | |
liver | 5 studies | 30% ± 7% | |
adipose | 4 studies | 29% ± 9% | |
pancreas | 3 studies | 35% ± 8% | |
placenta | 3 studies | 25% ± 9% | |
bone marrow | 3 studies | 23% ± 6% | |
breast | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 2090.47 | 328 / 328 | 100% | 60.28 | 178 / 178 |
prostate | 100% | 1985.81 | 245 / 245 | 100% | 64.12 | 502 / 502 |
breast | 100% | 1762.64 | 459 / 459 | 100% | 139.69 | 1117 / 1118 |
thymus | 100% | 2315.90 | 653 / 653 | 100% | 73.40 | 604 / 605 |
liver | 100% | 1708.71 | 226 / 226 | 100% | 55.17 | 405 / 406 |
lung | 100% | 2478.04 | 578 / 578 | 100% | 42.46 | 1152 / 1155 |
stomach | 100% | 1813.68 | 359 / 359 | 100% | 43.44 | 285 / 286 |
intestine | 100% | 1659.03 | 966 / 966 | 100% | 44.51 | 525 / 527 |
uterus | 100% | 1570.91 | 170 / 170 | 100% | 52.80 | 457 / 459 |
kidney | 100% | 1584.44 | 89 / 89 | 100% | 69.06 | 897 / 901 |
esophagus | 100% | 1572.69 | 1445 / 1445 | 99% | 36.67 | 182 / 183 |
bladder | 100% | 2665.57 | 21 / 21 | 99% | 46.36 | 497 / 504 |
adrenal gland | 100% | 1610.04 | 258 / 258 | 98% | 66.11 | 226 / 230 |
skin | 100% | 1601.64 | 1809 / 1809 | 97% | 52.90 | 456 / 472 |
brain | 95% | 557.20 | 2497 / 2642 | 97% | 25.61 | 687 / 705 |
ovary | 100% | 1326.17 | 180 / 180 | 89% | 22.68 | 384 / 430 |
adipose | 100% | 1657.47 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 33.22 | 29 / 29 |
spleen | 100% | 1424.49 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 43.36 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 16.91 | 1 / 1 |
blood vessel | 100% | 1451.78 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 951.49 | 846 / 861 | 0% | 0 | 0 / 0 |
muscle | 95% | 727.78 | 761 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 891.59 | 869 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 78% | 26.92 | 62 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006457 | Biological process | protein folding |
GO_0045861 | Biological process | negative regulation of proteolysis |
GO_0050708 | Biological process | regulation of protein secretion |
GO_0006417 | Biological process | regulation of translation |
GO_0012505 | Cellular component | endomembrane system |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0003677 | Molecular function | DNA binding |
GO_0051087 | Molecular function | protein-folding chaperone binding |
GO_0005515 | Molecular function | protein binding |
GO_0001671 | Molecular function | ATPase activator activity |
Gene name | DNAJC1 |
Protein name | DnaJ homolog subfamily C member 1 (DnaJ protein homolog MTJ1) DnaJ heat shock protein family (Hsp40) member C1 (DnaJ homolog subfamily C member 1 variant 3) (DnaJ homolog subfamily C member 1 variant 4) DNAJC1 protein |
Synonyms | HTJ1 |
Description | FUNCTION: May modulate protein synthesis. . |
Accessions | A4VCI1 Q5T1X2 ENST00000376980.8 ENST00000476103.3 Q96KC8 |